Unilife Corp. (NASDAQ: UNIS) announced they've got begun supplying Sanofi featuring a Unifill? syringe as per your terms of their agreement.
Unilife has received a total involving $40 million from Sanofi for the exclusivity of the Unifill syringe from the full therapeutic type of antithrombotic agents and vaccines in addition to several smaller subgroups up until August 2014.
The Unifill? ready-to-fill (prefilled) syringe is really a primary drug jar with passive (automated) safety features fully included within the glass barrel or clip. It is designed for incorporation into the fill-finish systems utilized for equivalent products, as well as supplied as per conventional handling processes. The actual Unifill syringe is similar in size to an equivalent conventional prefilled syringe and is significantly smaller than those supplied with an ancillary safe practices device. This units Unilifes product aside from all the others on the market.
To read much more about Unilife please visit com/Blog/bid/68160/Unilife-Begins-the-Supplying-of-Product-to-Sanofi-UNIS
Other lively stocks are Becton, Dickinson plus Co (NYSE: BDX), Thermo Fisher Controlled (NYSE: TMO) and Marine environments Corp (NYSE: WAT)
Information, thoughts and analysis comprised herein are based on options believed to be reliable, nevertheless no representation, stated or implied, is done as to its reliability, completeness or correctness. The viewpoints contained herein echo our current wisdom and are subject to adjust without notice. We agree to no liability for any losses arising from a strong investor's reliance on as well as use of this survey. This report is good for information purposes merely, and is neither your solicitation to buy nor an offer to sell securities. A 3rd party has hired in addition to paid IO News Line twelve hundred plus ninety five dollars for your publication and circulation of this news generate. Certain information involved herein is forward-looking while in the meaning of the Private Stock Litigation Reform React of 1995, which include, but not limited to, statements concerning manufacturing, advertising and marketing, growth, and enlargement. Such forward-looking information will involve important risks as well as uncertainties that could affect actual results in addition to cause them to differ materially through expectations expressed thus. We have no ownership of equity,ray ban 3322, zero representation; do no investing of any kind and deliver no faxes or email messages.
Contact:
Eric Jensen
com
516.942.4910
| 
没有评论:
发表评论